Amanda Pedersen, Medical Device and Diagnostics Industry Online
In a recent analyst report, Canaccord Genuity’s Jason Mills highlighted 16 promising MedTech companies in the private sector.
“Our research suggests there are a plethora of high-quality, highly-innovative and potentially disruptive medical technology companies in the private sphere, many of whom could explore the IPO route over the next several quarters,” Mills wrote in his report. “It’s never too early for investors to start learning about these compelling stories.”